Hirsutism

Gynecological Endocrinology

Volumn 25, Issue 3, 2009, Pages 140-148

  Shah, Duru ^a,b,c,d,f   Patel, Sukhpreet ^e  

^a Gynaecworld Assisted Fertility Unit   (India)

^b BREACH CANDY HOSPITAL   (India)

^c JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^d Sir Hurkisondas Nurrotumdas Hospital & Research Centre   (India)

^e Gynaecworld   (India)

^f Kemps Corner   (India)

Author keywords

Adrenal; Antiandrogens; Hirsutism; Polycystic ovarian syndrome

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANTIANDROGEN; DANAZOL; DROSPERINONE; EFLORNITHINE; ESTROGEN; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; GLUCOCORTICOID; INSULIN SENSITIZING AGENT; METFORMIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROGESTERONE DERIVATIVE; SEX HORMONE; SPIRONOLACTONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADRENAL CANCER; CLINICAL ASSESSMENT; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; DIZZINESS; DRUG MECHANISM; ELECTROLYSIS; ENZYME INHIBITION; FEMINIZATION; GROUPS BY AGE; HAIR GROWTH; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERKALEMIA; LABORATORY TEST; LOW DRUG DOSE; MENSTRUAL IRREGULARITY; NOCTURIA; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PHYSICAL EXAMINATION; POLYURIA; PRIORITY JOURNAL; RECEPTOR BLOCKING; REPRODUCTION; REVIEW; SYMPTOM; VIRILIZATION; WEIGHT REDUCTION;

ADRENAL GLANDS; CUSHING SYNDROME; FEMALE; GONADAL STEROID HORMONES; HAIR; HIRSUTISM; HUMANS; MODELS, BIOLOGICAL; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 67651215602     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802531567     Document Type: Review

References (29)

1. Mofid A, Ahmad S, Alinaghi S, Zandieh S, Yazdani T. Hirsutism. Int J Clin Pract 2008;62:433-443.
2. Nikolaoua D, Gilling-Smith C. Hirsutism. Curr Obstet Gynaecol 2005;15:174-182.
3. Lobo RA, Goebelsmann U, Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 1983;57:393-397.
4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
5. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
6. Kazer RR, Kessel B, Yen SSC. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1987;65:233-236.
7. Futterweit MD, Dunaif A, Yeh H-C, Kingsley P. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 1988;19:831-836.
8. Oláh KS. The modern management of hirsutism. Rev Gynecol Pract 2004;4:211-220.
9. Hawkins LA, Chasalow FI, Blethen SL. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/ oligomenorrhea. J Clin Endocrinol Metab 1992;74:248-253.
10. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocrinol Rev 2000;21:347-362.
11. Hassa H, Mete Tanir H, Yildirim A, Senses T, Eskalen M, Mutlu FS. The hirsutism scoring system should be population specific. Fertil Steril 2005;84:778-780.
12. Ferriman D, Galiwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
13. Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab 2006;20:177-191.
14. Sahin Y, Kelestimur F. Medical treatment regimens of hirsutism. Reprod Biomed Online 2004;8:538-546.
15. Koulianos G. Treatment of acne with oral contraceptives: criteria for pill selection. Cutis 2000;66:281-286.
16. Harper JC. Antiandrogen therapy for skin and hair disease. Dermatol Clin 2006;24:137-143.
17. Batukan C, Muderris II, Ozcelik B, Ozturk A. Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism. Gynecol Endocrinol 2007;23:38-44.
18. Vincenzo D, Giuseppe M, Paola P, Musacchio MC, Petraglia F, Cianci A. Evaluation of effects of an oral contraceptive containing ethinyl estradiol combined with drosperinone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. Fertil Steril 2007;88: 113-117.
19. Cem B, Ipek M. Efficacy of a new oral contraceptive containing drosperinone and ethinyl estradiol in long term treatment of hirsutism. Fertil Steril 2006;85:436-440.
20. Dinger JC, Heinemann LA, Habich DK. The safety of a drosperinone- containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344-354.
21. Swiglo BA, Cosma M, Flynn DN, Kurtz DM, Labella ML, Mullan RJ, Erwin PJ, Montori VM. Antiandrogens for the treatment of hirsutism: a systematic review and meta-analysis of randomised controlled trials. J Clin Endocrinol Metab 2008;93:1153-1160.
22. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database Syst Rev 2003;4:CD001125.
23. Farquhar C, Lee O, Toomath R, Jepson R. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2003;4: CD000194.
24. Beigi A, Sobhi A, Zarrinkoub F. Finasteride versus cyproter-one acetate-estrogen regimens in the treatment of hirsutism. Int J Gynaecol Obstet 2004;87:29-33.
25. Sahin Y, Bayram F, Kelestimur F, Muderris I. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. J Endocrinol Invest 1998;21:348-352.
26. Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf) 2008;68:800-805.
27. Harborne L, Fleming R, Lyall H, Sattar N, Norman J. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:4116-4123.
28. Moghetti P, Toscano V. Treatment of hirsutism and acne in hyperandrogenism. Best Pract Res Clin Endocrinol Metab 2006;20:221-234.
29. Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003;101:995-1007.